Drug profile · INN
corticotropin
PURIFIED CORTROPHIN GEL
corticotropin (PURIFIED CORTROPHIN GEL) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — corticotropin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 20
- Programs
- 4
- Data quality
- 0.84
Quick answer
corticotropin (PURIFIED CORTROPHIN GEL) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Melanocortin receptor 2 agonist
Primary target: Adrenocorticotropic hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12324787
Kits for preparing and delivering purified corticotropin
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12133831
Kits for preparing and delivering purified corticotropin
granted -
US 12115166
Corticotropin releasing factor receptor antagonists
granted -
US 12102662
Methods for storing and warming purified corticotropin compositions
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted -
US 11351177
Corticotropin releasing factor receptor antagonists
granted -
US 11344557
Corticotropin releasing factor receptor antagonists
granted -
US 11311549
Corticotropin releasing factor receptor antagonists
granted -
US 11202787
Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 11077108
Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition
granted -
US 11007201
Corticotropin releasing factor receptor antagonists
granted -
US 10849908
Corticotropin releasing factor receptor antagonists
granted -
US 10314850
Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 10231983
Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 8901141
Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
granted -
US 7285534
Corticotropin-releasing hormone analogs and their uses
granted -
US 7034118
Corticotropin-releasing factor2 receptors
expired -
US 6803359
Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
expired -
US 6723841
Corticotropin-releasing factor2 receptors
expired
Frequently asked questions
What is corticotropin?
corticotropin (PURIFIED CORTROPHIN GEL) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for corticotropin?
PURIFIED CORTROPHIN GEL is a marketed brand name for corticotropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of corticotropin?
corticotropin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.